PMID,Title,Journal,Year
39585882,Exploring bacterial key genes and therapeutic agents for breast cancer among the Ghanaian female population: Insights from In Silico analyses.,PloS one,2024
39226729,FDA-approved antivirals ledipasvir and daclatasvir downregulate the Src-EPHA2-Akt oncogenic pathway in colorectal and triple-negative breast cancer cells.,Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2024
38301858,FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC.,Biochimica et biophysica acta. General subjects,2024
33954893,Prospective Drug Candidates as Human Multidrug Transporter ABCG2 Inhibitors: an In Silico Drug Discovery Study.,Cell biochemistry and biophysics,2021
31685755,Estimating Efflux Transporter-Mediated Disposition of Molecules beyond the Rule of Five (bRo5) Using Transporter Gene Knockout Rats.,Biological & pharmaceutical bulletin,2020
31407252,Extrahepatic Malignancies After Treatment with Direct Antiviral Agents for Chronic HCV Infection.,Journal of gastrointestinal cancer,2020
30410039,Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.,The American journal of gastroenterology,2019
29509884,Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study.,The Journal of antimicrobial chemotherapy,2018
27530469,Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C.,British journal of clinical pharmacology,2017
